We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Metformin May Prolong Gestation in Preterm Pre-Eclampsia

By HospiMedica International staff writers
Posted on 05 Oct 2021
Print article
Image: Metformin can help increase gestation time in women with pre-eclampsia (Photo courtesy of Getty images)
Image: Metformin can help increase gestation time in women with pre-eclampsia (Photo courtesy of Getty images)
A new study suggests that administering extended release metformin can prolong gestation time in women with preterm pre-eclampsia.

Researchers at Monash University (Melbourne, Australia), Tygerberg Hospital (Cape Town, South Africa), and other institutions led a randomized, placebo controlled trial of 180 women with preterm pre-eclampsia under expectant management in order to evaluate if administering metformin (3 grams of oral extended release metformin, in divided doses, until delivery) could help prolong gestation. Ninety of the women were randomized to extended release metformin, and 90 to placebo. The main outcome was prolongation of gestation.

The results showed average time from randomization to delivery was 17.7 days in the metformin arm and 10.1 days in the placebo arm, an average difference of 7.6 days. Two more analyses were carried out, which showed that women who took metformin at any dose had an average 9.6 day longer gestation, while in women who took the full dose of metformin showed an average 11.5 day longer gestation. There were no differences in serious adverse events, birth complications, or death among both mothers and babies. The study was published on September 23, 2021, in The BMJ.

“Based on the findings of this study, we are cautiously optimistic that extended release metformin prolongs gestation in women with preterm pre-eclampsia,” concluded lead author Catherine Cluver, MD, and colleagues. “Further trials should be considered to confirm whether the drug can prolong gestation and to evaluate the benefits to neonates. Trials might also evaluate whether metformin can prevent worsening maternal organ dysfunction while birth is being planned among women with a diagnosis of late preterm pre-eclampsia, and even among those with pre-eclampsia at term.”

Preeclampsia is a complication of pregnancy characterized by hypertension and kidney dysfunction that can cause severe complications for both the mother (including seizures, stroke, renal failure, and liver dysfunction) and the infant (such as low birth weight, preterm delivery, and stillbirth). The condition also increases a woman's risk for cardiovascular disease (CVD) later in life. Currently, there is no cure for preeclampsia, and only childbirth can alleviate the symptoms. An estimated 10 million pregnant women develop preeclampsia annually, causing approximately 500,000 fetal and neonatal and 76,000 maternal deaths.

Related Links:
Monash University
Tygerberg Hospital



Print article

Channels

AI

view channel
Image: Cardiologs Holter arrhythmia diagnostic software is cloud-based, vendor-neutral and powered by AI (Photo courtesy of Cardiologs)

AI Predicts Short-Term Risk of Atrial Fibrillation Using 24-Hour Holter Recordings

Atrial Fibrillation (AFib) affects millions of people each year. However, the condition is often unrecognized and untreated. Nowadays, patients are subject to 24-hour ambulatory electrocardiograms (ECGs)... Read more

Critical Care

view channel
Image: Cutting-edge 4D flow MRI scans could revolutionize blood flow assessment in the heart (Photo courtesy of University of East Anglia)

4D Flow MRI Scans Could Revolutionize Diagnosis of Patients with Heart Failure

Researchers have developed cutting-edge imaging technology to help doctors better diagnose and monitor patients with heart failure. The state-of-the-art technology uses magnetic resonance imaging (MRI)... Read more

Surgical Techniques

view channel
Image: The Senhance surgical system with digital laparoscopy (Photo courtesy of Asensus Surgical)

Digital Laparoscopic Platform Leverages Augmented Intelligence and Machine Learning

Challenges in laparoscopic surgery can impact cost, utilization, effectiveness, and outcomes of the procedure. For instance, the inability of the surgeon to control vision can create efficiency and safety... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more

Business

view channel
Image: Expanding the role of autonomous robots can mitigate the shortage of physicians (Photo courtesy of Pexels)

Robot-Assisted Surgical Devices Market Driven by Increased Demand for Patient-Specific Surgeries

An aging population and accompanying retirements will cause a significant physician shortfall of 55,000 to 150,000 by 2030, creating a gap in the healthcare system. Expanding the role of autonomous robots... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.